Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload

Ellis J. Neufeld, Renzo Galanello, Vip Viprakasit, Yesim Aydinok, Antonio Piga, Paul Harmatz, Gian Luca Forni, Farrukh T. Shah, Rachael F. Grace, John B. Porter, John C. Wood, Jennifer Peppe, Amber Jones, Hugh Young Rienhoff, Jr

Blood (2012) 119 (14): 3263–3268.

https://doi.org/10.1182/blood-2011-10-386268

Published: 2012

Includes: Supplemental data

Journal Articles

Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study

Ellis J. Neufeld, MD, PhD, Renzo Galanello, MD, Vip Viprakasit, MD; DPhil, Yesim Aydinok, MD, Antonio Piga, MD, Paul Harmatz, MD, Gian Luca Forni, MD, Farrukh T Shah, MBBS, MD, Rachael F. Grace, MD, John B. Porter, MD, Elliott Vichinsky, MD, John C Wood, MD, Ph.D, Jennifer Peppe, Amber Jones, Hugh Y Rienhoff, Jr., MD

Blood (2011) 118 (21): 690.

https://doi.org/10.1182/blood.V118.21.690.690

Published: 2011

Journal Articles

A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality

Alison S Thomas, MBBS, Maciej Garbowski, MBBS, Ai Leen Ang, MBBS, Farrukh T Shah, MBBS, MD, J. Malcolm Walker, MBBS, James C Moon, MBBCh, MD, Dudley J Pennell, MD, John B Porter, MD

Blood (2010) 116 (21): 1011.

https://doi.org/10.1182/blood.V116.21.1011.1011

Published: 2010

Journal Articles

Deferiprone Is Associated with Lower Serum Ferritin (SF) Relative to Liver Iron Concentration (LIC) Than Deferoxamine and Deferasirox- Implications for Clinical Practice

Ai Leen Ang, MBBS, Farrukh T Shah, MD, Bernard A Davis, MD, Alison Thomas, MBBCh, BA, Govin Murugachandran, MBBS, BSc, Jeevan Kumuradevan, MBChB, Maciej W Garbowksi, LekMed, John B Porter, MD

Blood (2010) 116 (21): 4246.

https://doi.org/10.1182/blood.V116.21.4246.4246

Published: 2010

Journal Articles

Decreased Serum Pro-Hepcidin in Thalassaemia Intermedia; a Mechanism for Increased Iron Absortion Mediated Though Ineffective Erthropoiesis and NTBI?.

Farrukh T. Shah, Roozina Rafique, Patricia Evan, John B. Porter

Blood (2004) 104 (11): 3610.

https://doi.org/10.1182/blood.V104.11.3610.3610

Published: 2004

Journal Articles

Adults with Severe Sickle Cell Anaemia and Iron Overload Have a High Incidence of Osteopenia and Osteoporosis.

Farrukh T. Shah, Ratna Chatterjee, Matilda Owusu-Asante, John B. Porter

Blood (2004) 104 (11): 1684.

https://doi.org/10.1182/blood.V104.11.1684.1684

Published: 2004

NARROW

A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload

Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study

A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality

Deferiprone Is Associated with Lower Serum Ferritin (SF) Relative to Liver Iron Concentration (LIC) Than Deferoxamine and Deferasirox- Implications for Clinical Practice

Decreased Serum Pro-Hepcidin in Thalassaemia Intermedia; a Mechanism for Increased Iron Absortion Mediated Though Ineffective Erthropoiesis and NTBI?.

Adults with Severe Sickle Cell Anaemia and Iron Overload Have a High Incidence of Osteopenia and Osteoporosis.

Email alerts

ASH Publications

American Society of Hematology

A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload

Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study

A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality

Deferiprone Is Associated with Lower Serum Ferritin (SF) Relative to Liver Iron Concentration (LIC) Than Deferoxamine and Deferasirox- Implications for Clinical Practice

Decreased Serum Pro-Hepcidin in Thalassaemia Intermedia; a Mechanism for Increased Iron Absortion Mediated Though Ineffective Erthropoiesis and NTBI?.

Adults with Severe Sickle Cell Anaemia and Iron Overload Have a High Incidence of Osteopenia and Osteoporosis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only